98%
921
2 minutes
20
Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants that are widely detected in human serum worldwide, and are associated with reduced vaccine-induced antibody responses. However, existing research has primarily focused on the effects of prenatal and adolescent PFAS exposures on antibody levels or disease incidence. A critical gap remains in understanding the association between serum PFAS concentrations and antibody levels in children. In this study, we assessed the association of serum PFAS concentrations and antibody levels against measles, mumps, rubella, and varicella in children aged 3-12 years across all 11 administrative districts of Guangzhou, China. We compared the spatial distribution of serum PFAS concentrations across 11 administrative districts to reveal regional differences. We further evaluated both the individual and combined effects of PFAS on antibody levels, and employed interaction terms and stratified analyses to examine the modifying roles of age and sex. Children in Nansha District exhibited the highest total PFAS concentrations, with a noticeable decrease from south to north. We observed significant negative associations between perfluorobutanesulfonic acid and varicella antibody levels, as well as between perfluorooctanoic acid/6:2 chlorinated polyfluoroalkyl ether sulfonic acid and rubella antibody levels. In contrast, perfluoroheptanesulfonate showed significant positive associations with measles and rubella antibody levels. Trend analyses indicated a significant negative association between quartiles of total PFAS concentrations and rubella antibody levels, and Bayesian Kernel Machine Regression further demonstrated a gradual, significant decline in rubella antibody levels with increasing PFAS concentrations. Notably, these associations were more pronounced in girls and in younger age groups. Overall, our findings reveal marked spatial disparities in PFAS exposure and highlight a humoral immunosuppressive effect, particularly among younger children and girls.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.envpol.2025.127066 | DOI Listing |
J Neurol
September 2025
Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.
Objective: To evaluate the clinical efficacy of tocilizumab, a interleukin-6 (IL-6) receptor blocker, for the treatment of acute necrotizing encephalopathy (ANE).
Methods: PubMed, Cochrane Library, Embase, and Web of Science were searched for systematic review based on PRISMA guidelines. ANE patients treated with and without tocilizumab were included.
Transpl Immunol
September 2025
Molecular and Transplant Immunology Laboratory, Department of Transfusion Medicine (Blood Center), Medanta-The Medicity, Gurgaon, Haryana, India.
Over 60 % of kidney transplant candidates are non-sensitised while remaining 40 % are sensitised because of previous exposure to human alloantigens during previous transplants, blood transfusions, and pregnancy in women. Pre-transplant compatibility testing is mandatory prior to renal transplantation for detecting the presence of donor-specific antibodies (DSAs), which are associated with early hyperacute/acute and later chronic rejections. Initially, complement-dependent cytotoxicity crossmatch (CDCXM) was used as a traditional method for detecting preformed DSAs.
View Article and Find Full Text PDFAm J Transplant
September 2025
Institut de Transplantation Urologie Néphrologie (ITUN), CHU Nantes, Nantes, France; Centre de Recherche en Transplantation et Immunologie UMR1064, INSERM, Université de Nantes, Nantes, France. Electronic address:
A comprehensive analysis was performed on all consecutive biopsy-proven Thrombotic Microangiopathy (TMA) complicating kidney transplantation in the post C5 inhibitor era (from 2009) to identify pathological profiles, determine causes and establish risk factor associated with death-censored graft survival, in two French center. Pathological criteria were assessed according to the TMA Banff Working Group, followed by an unbiased analysis to identify distinct subgroups. 119 cases were identified, 8(6.
View Article and Find Full Text PDFInt J Radiat Oncol Biol Phys
September 2025
Department of Radiation Oncology, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India. Electronic address:
Purpose: Recent immunotherapy trials in locally advanced cervical cancer report high PD-L1 positivity rates whereas academic multicentric initiatives report a lower PD-L1 positivity. These observations necessitate cross-clone comparison to understand the observed differences.
Methods: Two different clones used in previous multicentric international studies SP142 (BIOEMBRACE) and 22C3 (KEYNOTE-A18) were used to test PD-L1 positivity in a pilot cohort of FIGO 2018 stage III cervical cancer patients recruited in a phase III trial.
Fish Shellfish Immunol
September 2025
College of Marine Sciences, South China Agricultural University, Guangzhou, 510642, China; Nansha-South China Agricultural University Fishery Research Institute, Guangzhou, 511464, China. Electronic address:
Sea perch is one of the most important fish species farmed in China. However, the frequent outbreak of viral diseases induced by sea perch iridovirus (SPIV) always caused high mortality and heavy economic losses in sea perch aquaculture. Up to now, no effective countermeasures against SPIV infection have been established.
View Article and Find Full Text PDF